By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has partnered with Integrated Diagnostics to develop multiplexed protein biomarker-based assays for detecting diseases in their early stages.

The firms plan to develop high-throughput automated workflows for sample preparation and liquid chromatography mass spectrometry analysis, with the goal of accelerating biomarker discoveries by enabling screening of several hundred biomarkers in a single assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.